Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6946247
RNAse probe protection assays in screening for modulators of immunoglobulin germline transcription
expired -
US 6887675
Tankyrase H, compositions involved in the cell cycle and methods of use
expired -
US 6824976
Method for selective inactivation of viral replication
expired -
US 6777179
Method for selective inactivation of viral replication
expired -
US 6759538
Substituted diphenyl heterocycles useful for treating HCV infection
expired -
US 6737232
IAPs associated cell cycle proteins, compositions and methods of use
expired -
US 6696263
PCNA associated cell cycle proteins, compositions and methods of use
expired -
US 6667152
Method for selective inactivation of viral replication
expired -
US 6623961
Method for selective inactivation of viral replication
expired -
US 6617102
Tankyrase H, compositions involved in the cell cycle and methods of use
expired -
US 6589725
Tankyrase H, compositions involved in the cell cycle and methods of use
expired -
US 6579674
Method for selective inactivation of viral replication
expired -
US 6387658
PCNA-associated cell cycle proteins, compositions and methods of use
expired